1. Home
  2. JAGX vs CNFR Comparison

JAGX vs CNFR Comparison

Compare JAGX & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • CNFR
  • Stock Information
  • Founded
  • JAGX 2013
  • CNFR 2009
  • Country
  • JAGX United States
  • CNFR United States
  • Employees
  • JAGX N/A
  • CNFR N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • CNFR Property-Casualty Insurers
  • Sector
  • JAGX Health Care
  • CNFR Finance
  • Exchange
  • JAGX Nasdaq
  • CNFR Nasdaq
  • Market Cap
  • JAGX 7.4M
  • CNFR 7.9M
  • IPO Year
  • JAGX N/A
  • CNFR 2015
  • Fundamental
  • Price
  • JAGX $4.06
  • CNFR $0.76
  • Analyst Decision
  • JAGX Strong Buy
  • CNFR
  • Analyst Count
  • JAGX 1
  • CNFR 0
  • Target Price
  • JAGX $60.00
  • CNFR N/A
  • AVG Volume (30 Days)
  • JAGX 108.8K
  • CNFR 11.1K
  • Earning Date
  • JAGX 05-15-2025
  • CNFR 05-14-2025
  • Dividend Yield
  • JAGX N/A
  • CNFR N/A
  • EPS Growth
  • JAGX N/A
  • CNFR N/A
  • EPS
  • JAGX N/A
  • CNFR 1.96
  • Revenue
  • JAGX $11,552,000.00
  • CNFR $64,021,000.00
  • Revenue This Year
  • JAGX $22.41
  • CNFR $25.91
  • Revenue Next Year
  • JAGX $30.00
  • CNFR N/A
  • P/E Ratio
  • JAGX N/A
  • CNFR $0.38
  • Revenue Growth
  • JAGX 13.93
  • CNFR N/A
  • 52 Week Low
  • JAGX $3.75
  • CNFR $0.42
  • 52 Week High
  • JAGX $110.75
  • CNFR $1.91
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 33.50
  • CNFR 47.88
  • Support Level
  • JAGX $4.27
  • CNFR $0.75
  • Resistance Level
  • JAGX $4.90
  • CNFR $0.85
  • Average True Range (ATR)
  • JAGX 0.49
  • CNFR 0.03
  • MACD
  • JAGX -0.04
  • CNFR -0.01
  • Stochastic Oscillator
  • JAGX 9.27
  • CNFR 18.85

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About CNFR Conifer Holdings Inc.

Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.

Share on Social Networks: